Antiangiogenesis is produced by nontoxic doses of vinblastine

Blood

Volumn 94, Issue 12, 1999, Pages 4143-4155

  Vacca, Angelo ^b   Iurlaro, Monica ^b   Ribatti, Domenico ^b   Minischetti, Monica ^b   Nico, Beatrice ^b   Ria, Roberto ^b   Pellegrino, Antonio ^b   Dammacco, Franco ^a  

^a POLICLINICO   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; GELATINASE A; GELATINASE B; VINBLASTINE;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CHEMOTAXIS; CHICK EMBRYO; CHRONIC DISEASE; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; KAPOSI SARCOMA; NONHUMAN; PRIORITY JOURNAL;

EID: 0032762952     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.12.4143     Document Type: Article

References (45)

1. Olmsted JB, Borisy GG: Microtubules. Annu Rev Biochem 42:507, 1973
2. Wilson L: Microtubules as drug receptors: Pharmacological properties of microtubular protein. Ann NY Acad Sci USA 253:213, 1977
3. Shwartsmann G, Bender RA: Vinca alkaloids, in Pinedo HM, Longo DL, Chabner BA (eds): Cancer Chemoterapy and Biological Response Modifiers Annual, vol 10. Amsterdam, The Netherlands, Excerpta Medica, 1988, p 50
4. Doll DC, Ringenberg QS, Yarbro JW: Vascular toxicity associated with antineoplastic agents. J Clin Oncol 4:1405, 1986
5. Chaplin DJ: The effect of therapy on tumour vascular function. Int J Radiat Biol 60:311, 1991
6. Nicolson GL, Custead SE: Effects of chemotherapeutic drugs on platelet and metastatic tumor cell-endothelial cell interactions as a model for assessing vascular endothelial integrity. Cancer Res 45:331, 1985
7. Denekamp J, Hill SA, Hobson B: Vascular occlusion and tumour cell death. Eur J Cancer Clin Oncol 19:271, 1983
8. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nature Med 1:27, 1995
9. Baguley BC, Holdaway KM, Thomsen LL, Zhuang L, Zwi LJ: Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine: Evidence for a vascular mechanism. Eur J Cancer 27:482, 1991
10. Peter FW, Schuschke DA, Barker JH, Fleischer-Peter B, Hussmann J, Steinau HU: Leukocyte behaviour in a free-flap model following chemotherapy and application of granulocyte colony-stimulating factor. Microsurgery 18:290, 1998
11. Bussolino F, Di Renzo MF, Ziche M, Bocchietto E, Olivero M, Naldini L, Gaudino G, Tamagnone L, Coffer A, Comoglio PM: Hepatocyte growth factor is a potent angiogenic growth factor which stimulates endothelial cell motility and growth. J Cell Biol 119:629, 1992
12. Edgell CJ, McDonald CC, Graham JB: Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci USA 80:3734, 1983
13. Jackson A, Friedman S, Zhan X, Engleka K, Forough R, Maciag T: Heat shock induces the release of fibroblast growth factor I from NIH 3T3 cells. Proc Natl Acad Sci USA 89:10691, 1992
14. Kueng K, Silfer E, Eppenberger V: Quantification of cells cultured on 96-well plates. Anal Biochem 182:16, 1989
15. Iurlaro M, Vacca A, Minischetti M, Ribatti D, Pellegrino A, Sardanelli A, Giacchetta F, Dammacco F: Antiangiogenesis by cyclosporine. Exp Hematol 26:1215, 1998
16. Eliceiri BP, Cheresh DA: The role of αv integrins during angiogenesis: Insights into potential mechanisms of action and clinic development. J Clin Invest 103:1227, 1999
17. Vacca A, Ribatti D, Presta M, Minischetti M, Iurlaro M, Ria R, Albini A, Bussolino F, Dammacco F: Bone marrow neovascularization, plasma cell angiogenic potential and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood 93:3064, 1999
18. Silvestris F, Nagata S, Cafforio P, Silvestris N, Dammacco F: Cross-linking of FAS by antibodies to a peculiar domain of gp120 V3 loop can enhance T cell apoptosis in HIV-1 infected patients. J Exp Med 184:2287, 1996
19. Petit PX, LeCoeur H, Zorn E, Dauguet C, Mignotte B, Gougeon ML: Alterations of mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J Cell Biol 130:157, 1995
20. Ribatti D, Urbinati C, Nico B, Rusnati M, Roncali L, Presta M: Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane. Dev Biol 170:39, 1995
21. 3 for angiogenesis. Science 264:569, 1994
22. Olivo M, Bhardway R, Schulze-Osthoff K, Jürgen-Jacob H, Flamme I: A comparative study on the effects of tumor necrosis factor-α (TNF-α), human angiogenic factor (h-AF) and basic fibroblast growth factor (bFGF) on the chorioallantoic membrane of the chick embryo. Anat Rec 234:105, 1992
23. Ribatti D, Presta M, Vacca A, Ria R, Giuliani R, Dell'Era P, Nico B, Roncali L, Dammacco F: Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 93:2627, 1999
24. Pepper MS: Positive and negative regulation of angiogenesis: From cell biology to the clinic. Vasc Med 1:259, 1996
25. Zetter BR: Angiogenesis and tumor metastasis. Annu Rev Med 49:407, 1998
26. van Wart HE, Birkedal-Hansen H: The cystein switch: A principle of regulation of metalloproteases gene family. Proc Natl Acad Sci USA 85:5578, 1990
27. El Hafny B, Cano N, Piciotti M, Regina A, Schermann JM, Roux F: Role of P-glycoprotein in colchicine and vinblastine cellular kinetics in an immortalized rat brain microvessel endothelial cell line. Biochem Pharmacol 53:1735, 1997
28. Watts ME, Woodcock M, Arnold S, Chaplin DJ: Effects of novel and conventional anti-cancer agents on human endothelial permeability: Influence of tumour secreted factors. Anticancer Res 17:71, 1997
29. Kitazumi K, Mio M, Tasaka K: Involvement of the microtubular system in the endothelin-1 secretion from porcine aortic endothelial cells. Biochem Pharmacol 42:1079, 1991
30. Hill SA, Lonergan SJ, Denekamp J, Chaplin DJ: Vinca alkaloids: Antivascular effects in a murine tumour. Eur J Cancer 29A: 1320, 1993
31. Hill SA, Sampson LE, Chaplin DJ: Anti-vascular approaches to solid tumour therapy: Evaluation of vinblastine and flavone acetic acid. Int J Cancer 63:119, 1995
32. Chaplin DJ, Pettit GR, Parkins CS, Hill SA: Antivascular approaches to solid tumour therapy: Evaluation of tubulin binding agents. Br J Cancer 74:S86, 1996 (suppl 27)
33. Paku S: Current concepts of tumor-induced angiogenesis. Pathol Oncol Res 4:62, 1998
34. Risau W: Mechanism of angiogenesis. Nature 386:671, 1997
35. Kuijpers TW, Raleigh M, Kavanagh T, Janssen H, Calafat J, Roos D, Harlan JM: Cytokine-activated endothelial cells internalize E-selectin into a lysosomal compartment of vesciculotubular shape. A tubulin-driven process. J Immunol 152:5060, 1994
36. Ribatti D, Vacca A, Roncali L, Dammacco F: The chick embryo chorioallantoic membrane as a model for in vivo research on angiogenesis. Int J Devel Biol 40:1189:1996
37. Gagliardi AR, Kassack M, Kreimeyer A, Muller G, Nickel P, Collins DC: Antiangiogenic and antiproliferative activity of suramin analogues. Cancer Chemother Pharmacol 41:117, 1998
38. Ziche M, Donnini S, Morbidelli L, Parenti A, Gasparini G, Ledda F: Linomide blocks angiogenesis by breast carcinoma vascular endothelial growth factor transfectants. Br J Cancer 77:1123, 1998
39. Tanaka T, Manome Y, Wen P, Kufe DW, Fine HA: Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth. Nature Med 3:437, 1997
40. Dezube BJ, Von Roenn JH, Holden-Wiltse J, Cheung TW, Remick SC, Cooley TP, Moore J, Sommadossi JP, Shriver SL, Suckow CW, Gill PS: Fumagillin analog in the treatment of Kaposi's sarcoma: A phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team. J Clin Oncol 16:1444, 1998
41. Shaw M, Rotanawong S, Chou P, Ray V, Mirochnik Y, Slobodsky L, Rubenstein M, Guinan P: Paclitaxel, bropirimine and linomide: Effect on growth inhibition in a murine prostate cancer model by different growth regulatory mechanisms. Methods Find Exp Clin Pharmacol 20:111, 1998
42. Jones A, Harris AL: New developments in angiogenesis: A major mechanism for tumor growth and target for therapy. Cancer J Sci Am 4:209, 1998
43. Samaniego F, Markham PD, Gendelman R, Watanabe Y, Kao V, Kowalski K, Sonnabend JA, Pintus A, Gallo RC, Ensoli B: Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development. Am J Pathol 152:1433, 1998
44. Koch AE: Angiogenesis: Implications for rheumatoid arthritis. Arthritis Rheum 41:951, 1998
45. Ceponis A, Konttinen YT, Imai S, Tamulaitiene M, Li TF, Xu JW, Hietanen J, Santavirta S, Fassbender HG: Synovial lining, endothelial and inflammatory mononuclear cell proliferation in synovial membranes in psoriatic and reactive arthritis: A comparative quantitative morphometric study. Br J Rheumatol 37:170, 1998